Idiopathic Nephrotic Syndrome

SAN DIEGO — Health care providers and advocates must confront social disparities among patients with kidney disease to improve the standard of care, American Society of Nephrology President Deidra C. Crews, MD, ScM, FASN, said.

Mycophenolate mofetil may be a viable alternative to steroids for induction therapy in children with steroid-sensitive idiopathic nephrotic syndrome, researchers found in a study.